Article
Single-day accelerated TMS with D-cycloserine augmentation for depression: A placebo-controlled trial
2025-12-11
Abstract excerpt
<title>Abstract</title> <p>Accelerated transcranial magnetic stimulation (TMS) protocols have the potential to rapidly treat depression, yet the synaptic mechanisms underlying these intensive interventions remain poorly understood. d-cycloserine (DCS), a partial NMDAR agonist, enhances TMS-induced corticomotor plasticity and conventional daily TMS outcomes, but its effects on accelerated protocols are unknown. We...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30880fb3-97af-5fbc-852d-3049586f64d3
- DOI
- 10.21203/rs.3.rs-7980692/v1
